版本:
中国

BRIEF-Genentech says FDA grants breakthrough therapy designation for Rituximab in Pemphigus Vulgaris

March 24 Genentech:

* FDA grants breakthrough therapy designation for Rituxan (rituximab) in Pemphigus Vulgaris

* U.S. Food and drug administration (fda) has granted breakthrough therapy designation status to Rituxan Source text for Eikon:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐